White Paper

The Evolving Role of the Biopharma and Medtech CIO

How to Succeed in Today's Digital Era

The role of the healthcare CIO is evolving. While CIOs still spend 80% of their time solving legacy IT issues—and just 20% of their time on digital strategy—top companies are placing more emphasis on digital, and it’s paying off. Biopharma and medtech companies that evolve the CIO role realize market share gains of around 7%.

To explore the evolving role of the CIO and find best practices for a successful digital health strategy, BrightInsight, Inc. and The Boston Consulting Group spoke with CIOs from the top biopharma and medtech companies and leading health systems including the following executives:

  • David Smoley, Chief Information Officer, AstraZeneca
  • Paul von Autenried, Chief Information Officer, Bristol-Myers Squibb
  • Kristin Darby, Chief Information Officer, Cancer Treatment Centers of America
  • Aarti Shah, Chief Information Officer, Lilly
  • Scott Sandschafer, Chief Information Officer, Novartis
  • Anders Romare, Chief Information Officer, Novo Nordisk
  • Raj Sodhi, President, SaaS Business, ResMed

In this white paper and compendium, we discuss how CIOs can build a digital strategy and leverage an Internet of Things platform that:

  • Provides security and privacy
  • Addresses complex regulatory burdens
  • Serves up analytics by turning massive amounts of data into insights
  • Delivers scalability across regions, brands, and health IT systems
  • Uses advanced AI, machine learning, and IoT technologies